Vertex Pharmaceuticals Non-GAAP EPS of $3.05 beats by $0.05, revenue of $2.37B beats by $30M (NASDAQ:VRTX)

Vertex Pharmaceuticals press release (VRTX): Q1 Non-GAAP EPS of $3.05 beats by $0.05.Revenue of $2.37B (+12.9% Y/Y) beats by $30M. Company reiterates full year 2023 financial…